Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 28, 2018 11:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix to Present at the LD Micro 11th Annual Main Event on December 5, 2018

WALTHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix, is scheduled to speak at the...
November 20, 2018 10:41 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,130,810 titled...
November 15, 2018 12:50 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Announces DPNCheck Collaboration Agreement with Fukuda Denshi for Japan Market

WALTHAM, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), announced today that it had executed a distribution agreement with Fukuda Denshi Co. Ltd. for DPNCheck®, the...
October 31, 2018 11:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

WALTHAM, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,112,040 titled...
October 18, 2018 11:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Reports DPNCheck to be Featured at Upcoming 33rd Japan Society of Diabetic Complications Annual Meeting in Tokyo

WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), reported that DPNCheck®, its rapid, point-of-care test for diabetic peripheral neuropathy (DPN), will be featured...
October 17, 2018 07:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Reports Q3 2018 Financial Results

WALTHAM, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended September 30, 2018. The Company...
October 10, 2018 11:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix, Inc. Announces Date for 2018 Third Quarter Financial Results Conference Call

WALTHAM, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2018 third quarter financial results before the opening of the market...
October 02, 2018 11:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Reports Publication of New Clinical Study on Quell Wearable Pain Relief Technology

WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported publication of a clinical study of Quell® wearable pain relief in the Journal of Pain and Relief. ...
September 25, 2018 10:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix To Present Quell 2.0 at DTxDM East: The Digital Therapeutics and Digital Medicine Event in Boston

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today announced that it will showcase its latest product innovation, Quell® 2.0 Wearable Pain Relief Technology™,...
September 20, 2018 13:00 ET | Source: NeuroMetrix, Inc.

NeuroMetrix Reports Discussion of Quell Wearable Pain Relief Technology on the Fox Business Network

WALTHAM, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), reported that its President and CEO, Dr. Shai N. Gozani, yesterday participated in a discussion of the opioid...